Delcath Systems News

Delcath Systems to Host First Quarter 2024 Earnings Call

QUEENSBURY, N.Y., May 7, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announc

PR NewswireMay 7 08:30 ET

Delcath Systems Says Phase 3 Data on Hepzato Kit Published in Oncology Journal

Delcath Systems (DCTH) said Monday that the results from the pivotal phase 3 study of Hepzato Kit in unresectable metastatic uveal melanoma were published in the Annals of Surgical Oncology journal. T

MT NewswiresMay 6 10:23 ET

Publication of Results From Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients Treated With HEPZATO KIT

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver,...

PR NewswireMay 6 09:00 ET

Express News | Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersMay 3 17:15 ET

Express News | Delcath Systems: Files Prospectus Relates to Offer and Resale of up to 1.91 Mln Shares of Common Stock, From Time to Time, by Selling Stockholders

ReutersApr 29 16:50 ET

Express News | Delcath Systems Inc - Amendment to Agreement With Synerx Pharma, LLC and Mylan Teoranta, for Co's Supply of Melphalan Hydrochloride

ReutersApr 26 08:29 ET

Express News | Delcath Systems: On April 22, Co Amended, Effective May 1, to License, Supply and Contract Manufacturing Deal With Synerx Pharma and Mylan Teoranta

ReutersApr 26 08:28 ET

Express News | Delcath Systems Inc - Modifies the Price per Vial for the Product

ReutersApr 26 08:27 ET

Express News | Delcath Systems Inc - Extends the Term of the Agreement to December 31, 2028

ReutersApr 26 08:26 ET

Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and...

PR NewswireApr 4 08:35 ET

Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2023 Earnings Call Transcript

Yahoo FinanceMar 27 11:35 ET

Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays c

BenzingaMar 27 08:40 ET

Delcath Systems Is Maintained at Buy by HC Wainwright & Co.

Delcath Systems Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMar 27 06:35 ET

HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $20

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Delcath Systems with a Buy and raises the price target from $18 to $20.

Analyst UpgradesMar 27 06:24 ET

Delcath Systems Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/27/2024 338.6% HC Wainwright & Co. $18 → $20 Maintains Buy 09/07/2023 360.53% Canaccord Genuity $18 → $

BenzingaMar 27 06:23 ET

Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Aerovate Therapeutics (AVTE) and Delcath Systems (DCTH)

TipRanksMar 27 06:10 ET

Q4 2023 Delcath Systems Inc Earnings Call

Yahoo FinanceMar 26 21:54 ET

Earnings Call Summary | Delcath Systems(DCTH.US) Q4 2023 Earnings Conference

The following is a summary of the Delcath Systems Inc (DCTH) Q4 2023 Earnings Call Transcript:Financial Performance:Delcath Systems Inc. ended Q4 2023 with $32.5 million in cash and investments.Revenu

moomoo AIMar 26 13:06 ET · Conference Call

Delcath Systems Inc (DCTH) Reports Mixed Year-End Financials Amidst Strategic Advancements

Yahoo FinanceMar 26 09:12 ET

Earnings Flash (DCTH) DELCATH SYSTEMS Reports Q4 Revenue $539,000, Vs. Street Est of $550,000

07:43 AM EDT, 03/26/2024 (MT Newswires) -- Earnings Flash (DCTH) DELCATH SYSTEMS Reports Q4 Revenue $539,000, vs. Street Est of $550,000

MT NewswiresMar 26 07:43 ET